Free Newsletter
Therapy restores lost memory in Alzheimer's model
A team of researchers at MIT has discovered that a combination of mental stimulation and histone deacetylase, or HDAC, inhibitors can restore lost memories in mice engineered to develop Alzheimer's. Most of the new therapies in development for Alzheimer's are targeting the early stage of the disease. But these researchers found that even after Alzheimer's has caused severe memory loss, the therapeutic combination could be effective in helping restore learning and memory. The British journal Nature published their findings.
- read the report from the BBC
ALSO: Over-the-counter pain medication naproxen and prescription pain reliever celecoxib do not prevent Alzheimer's disease, according to new research. Release
Related Articles:
BRNI discovery raises hopes for Alzheimer's test. report
Progress made in identifying Alzheimer biomarkers. Report
Gene abnormality linked to Alzheimer's. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: